{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:29:00Z","timestamp":1783034940769,"version":"3.54.6"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008968","name":"National Research Council Sri Lanka","doi-asserted-by":"publisher","award":["NRC-19-030"],"award-info":[{"award-number":["NRC-19-030"]}],"id":[{"id":"10.13039\/100008968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008968","name":"National Research Council Sri Lanka","doi-asserted-by":"publisher","award":["NRC-19-030"],"award-info":[{"award-number":["NRC-19-030"]}],"id":[{"id":"10.13039\/100008968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008968","name":"National Research Council Sri Lanka","doi-asserted-by":"publisher","award":["NRC-19-030"],"award-info":[{"award-number":["NRC-19-030"]}],"id":[{"id":"10.13039\/100008968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008968","name":"National Research Council Sri Lanka","doi-asserted-by":"publisher","award":["NRC-19-030"],"award-info":[{"award-number":["NRC-19-030"]}],"id":[{"id":"10.13039\/100008968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008968","name":"National Research Council Sri Lanka","doi-asserted-by":"publisher","award":["NRC-19-030"],"award-info":[{"award-number":["NRC-19-030"]}],"id":[{"id":"10.13039\/100008968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008968","name":"National Research Council Sri Lanka","doi-asserted-by":"publisher","award":["NRC-19-030"],"award-info":[{"award-number":["NRC-19-030"]}],"id":[{"id":"10.13039\/100008968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008968","name":"National Research Council Sri Lanka","doi-asserted-by":"publisher","award":["NRC-19-030"],"award-info":[{"award-number":["NRC-19-030"]}],"id":[{"id":"10.13039\/100008968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03738-w","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T08:20:56Z","timestamp":1741594856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between single nucleotide polymorphisms in PNPLA3, TM6SF2 and MBOAT7 genes and markers of cancer aggressiveness in a Sri Lankan NASH-related HCC cohort"],"prefix":"10.1186","volume":"25","author":[{"given":"Saumya Madushani","family":"Samarasinghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asanka Sudeshini","family":"Hewage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan Chaminda","family":"Siriwardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamani Hemamala","family":"Tennekoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madunil Anuk","family":"Niriella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumadee","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visula","family":"Abeysuriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"3738_CR1","first-page":"e19274","volume":"13","author":"CA Philips","year":"2021","unstructured":"Philips CA, Rajesh S, Nair DC, Ahamed R, Abduljaleel JK, Augustine P. Hepatocellular carcinoma in 2021: an exhaustive update. Cureus. 2021;13:e19274.","journal-title":"Cureus"},{"key":"3738_CR2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to non-alcoholic fatty liver disease. Nat Genet. 2008;40:1461\u20135.","journal-title":"Nat Genet"},{"key":"3738_CR3","doi-asserted-by":"publisher","first-page":"4847","DOI":"10.1038\/s41467-024-49224-x","volume":"15","author":"SM Johnson","year":"2024","unstructured":"Johnson SM, Bao H, McMahon CE, Chen Y, Burr SD, Anderson AM, et al. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein. Nat Commun. 2024;15:4847.","journal-title":"Nat Commun"},{"key":"3738_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/hep.23759","volume":"52","author":"Y Rotman","year":"2010","unstructured":"Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, NASH CRN. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology. 2010;52:894\u2013903.","journal-title":"Hepatology"},{"key":"3738_CR5","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","volume":"285","author":"S He","year":"2010","unstructured":"He S, McPhaul C, Li JZ, Garuti R, Kinch L, Grishin NV, et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem. 2010;285:6706\u201315.","journal-title":"J Biol Chem"},{"key":"3738_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1194\/jlr.M046607","volume":"55","author":"H Ruhanen","year":"2014","unstructured":"Ruhanen H, Perttil\u00e4 J, H\u00f6ltt\u00e4-Vuori M, Zhou Y, Yki-J\u00e4rvinen H, Ikonen E, et al. PNPLA3 mediates hepatocyte triacylglycerol remodeling. J Lipid Res. 2014;55:739\u201346.","journal-title":"J Lipid Res"},{"key":"3738_CR7","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3390\/cancers13061412","volume":"13","author":"N Eldafashi","year":"2021","unstructured":"Eldafashi N, Darlay R, Shukla R, McCain MV, Watson R, Liu YL, et al. A PDCD1 role in the genetic predisposition to NAFLD-HCC? Cancers (Basel). 2021;13:1412.","journal-title":"Cancers (Basel)"},{"key":"3738_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.21873\/invivo.13139","volume":"37","author":"H Enomoto","year":"2023","unstructured":"Enomoto H, Aizawa N, Ikeda N, Takashima T, Yuri Y, Okamoto M, et al. Association of PNPLA3 SNP With the development of HBV-related hepatocellular carcinoma. In Vivo. 2023;37:763\u201370.","journal-title":"In Vivo"},{"key":"3738_CR9","doi-asserted-by":"publisher","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","volume":"286","author":"Y Huang","year":"2011","unstructured":"Huang Y, Cohen JC, Hobbs HH. Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J Biol Chem. 2011;286:37085\u201393.","journal-title":"J Biol Chem"},{"key":"3738_CR10","first-page":"S0168","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Hong S, Hudson H, Kory N, Kinch LN, Kozlitina J, et al. PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis. J Hepatol. 2024;15:S0168-8278.","journal-title":"J Hepatol"},{"issue":"3","key":"3738_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.5009\/gnl17306","volume":"12","author":"GE Chung","year":"2018","unstructured":"Chung GE, Lee Y, Yim JY, Choe EK, Kwak MS, Yang JI, et al. Genetic polymorphisms of PNPLA3 and SAMM50 Are associated with nonalcoholic fatty liver disease in a korean population. Gut and liver. 2018;12(3):316\u201323.","journal-title":"Gut and liver"},{"issue":"26","key":"3738_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.4254\/wjh.v9.i26.1101","volume":"9","author":"G Bale","year":"2017","unstructured":"Bale G, Steffie AU, Ravi Kanth VV, Rao PN, Sharma M, Sasikala M, et al. Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities. World J Hepatol. 2017;9(26):1101\u20137.","journal-title":"World J Hepatol"},{"key":"3738_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina J, Smagris E, Stender S, Nordestgaard BG, Zhou HH, Tybj\u00e6rg-Hansen A, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014;46:352\u20136.","journal-title":"Nat Genet"},{"key":"3738_CR14","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1038\/ncomms5309","volume":"5","author":"YL Liu","year":"2014","unstructured":"Liu YL, Reeves H, Burt A, Tiniakos D, McPherson S, Leathart JB, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun. 2014;5:4309.","journal-title":"Nat Commun"},{"key":"3738_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/hep.28283","volume":"63","author":"M Goffredo","year":"2016","unstructured":"Goffredo M, Caprio S, Feldstein AE, D\u2019Adamo E, Shaw MM, Pierpont B, et al. Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study. Hepatology. 2016;63:117\u201325.","journal-title":"Hepatology"},{"key":"3738_CR16","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1186\/s12885-019-6173-4","volume":"19","author":"S Tang","year":"2019","unstructured":"Tang S, Zhang J, Mei TT, Guo HQ, Wei XH, Zhang WY, et al. Association of TM6SF2 rs58542926 T\/C gene polymorphism with hepatocellular carcinoma: a meta-analysis. BMC Cancer. 2019;19:1128.","journal-title":"BMC Cancer"},{"key":"3738_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","volume":"150","author":"RM Mancina","year":"2016","unstructured":"Mancina RM, Dongiovanni P, Petta S, Pingitore P, Meroni M, Rametta R, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in Individuals of European descent. Gastroenterology. 2016;150:1219-1230.e6.","journal-title":"Gastroenterology"},{"key":"3738_CR18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.mayocp.2015.06.018","volume":"90","author":"W Zhang","year":"2015","unstructured":"Zhang W, Wang X, Jiang R, Hou J, Mu X, Li G, et al. Effect of tumor size on cancer-specific survival in small hepatocellular carcinoma. Mayo Clin Proc. 2015;90:1187\u201395.","journal-title":"Mayo Clin Proc"},{"key":"3738_CR19","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.2147\/CMAR.S177663","volume":"10","author":"GY Wu","year":"2018","unstructured":"Wu GY, Wu J, Wang BH, Zhu X, Shi X, Ding Y. Importance of tumor size at diagnosis as a prognostic factor for hepatocellular carcinoma survival: a population-based study. Cancer Manag Res. 2018;10:4401\u201310.","journal-title":"Cancer Manag Res"},{"key":"3738_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/jso.24099","volume":"113","author":"BK Goh","year":"2016","unstructured":"Goh BK, Teo JY, Chan CY, Lee SY, Jeyaraj P, Cheow PC, et al. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: implications on the current AJCC staging system. J Surg Oncol. 2016;113:89\u201393.","journal-title":"J Surg Oncol"},{"key":"3738_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9440(10)65248-0","volume":"154","author":"N Wong","year":"1999","unstructured":"Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, et al. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol. 1999;154:37\u201343.","journal-title":"Am J Pathol"},{"key":"3738_CR22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/lt.20472","volume":"11","author":"TM Pawlik","year":"2005","unstructured":"Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, et al. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086\u201392.","journal-title":"Liver Transpl"},{"key":"3738_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4174\/astr.2016.91.3.104","volume":"91","author":"JH Noh","year":"2016","unstructured":"Noh JH, Kim TS, Ahn KS, Kim YH, Kang KJ. Prognostic factors after hepatic resection for the single hepatocellular carcinoma larger than 5 cm. Ann Surg Treat Res. 2016;91:104\u201311.","journal-title":"Ann Surg Treat Res"},{"key":"3738_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.7150\/ijbs.64537","volume":"18","author":"X Hu","year":"2022","unstructured":"Hu X, Chen R, Wei Q, Xu X. The landscape of alpha fetoprotein in hepatocellular carcinoma: where are we? Int J Biol Sci. 2022;18:536\u201351.","journal-title":"Int J Biol Sci"},{"key":"3738_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","volume":"12","author":"M Lagos-Quintana","year":"2002","unstructured":"Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002;12:735\u20139.","journal-title":"Curr Biol"},{"key":"3738_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","volume":"424","author":"H Yamada","year":"2013","unstructured":"Yamada H, Suzuki K, Ichino N, Ando Y, Sawada A, Osakabe K, et al. Associations between circulating micro RNAs (miR-21, miR-34a, miR- 122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta. 2013;424:99\u2013103.","journal-title":"Clin Chim Acta"},{"key":"3738_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, et al. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37:266.","journal-title":"J Exp Clin Cancer Res"},{"key":"3738_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.21873\/anticanres.11358","volume":"37","author":"H Zeng","year":"2017","unstructured":"Zeng H, Wu HC, Wang Q, Yang HI, Chen CJ, Santella RM, et al. Telomere length and risk of hepatocellular carcinoma: a nested case-control study in taiwan cancer screening program cohort. Anticancer Res. 2017;37:637\u201344.","journal-title":"Anticancer Res"},{"key":"3738_CR29","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1002\/cncr.26015","volume":"117","author":"J Liu","year":"2011","unstructured":"Liu J, Yang Y, Zhang H, Zhao S, Liu H, Ge N, et al. Longer leukocyte telomere length predicts increased risk of Hepatitis B virus-related hepatocellular carcinoma: a case-control analysis. Cancer. 2011;117:4247\u201356.","journal-title":"Cancer"},{"key":"3738_CR30","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/j.1440-1746.2009.05831.x","volume":"24","author":"AS Dassanayake","year":"2009","unstructured":"Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, et al. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009;24:1284\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"3738_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/liv.12624","volume":"35","author":"A Kasturiratne","year":"2015","unstructured":"Kasturiratne A, Akiyama K, Niriella MA, Takeuchi F, Isono M, Dassanayake AS, et al. Association of genetic variants with non-alcoholic fatty liver disease in an urban Sri Lankan community. Liver Int. 2015;35:676\u20139.","journal-title":"Liver Int"},{"key":"3738_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/JHC.S159581","volume":"6","author":"D Geh","year":"2019","unstructured":"Geh D, Rana FA, Reeves HL. Weighing the benefits of hepatocellular carcinoma surveillance against potential harms. J Hepatocell Carcinoma. 2019;6:23\u201330.","journal-title":"J Hepatocell Carcinoma"},{"key":"3738_CR33","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","volume":"75","author":"GN Ioannou","year":"2021","unstructured":"Ioannou GN. Epidemiology and risk-stratification of NAFLD-associated HCC. J Hepatol. 2021;75:1476\u201384.","journal-title":"J Hepatol"},{"key":"3738_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","volume":"74","author":"C Bianco","year":"2021","unstructured":"Bianco C, Jamialahmadi O, Pelusi S, Baselli G, Dongiovanni P, Zanoni I, et al. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. J Hepatol. 2021;74:775\u201382.","journal-title":"J Hepatol"},{"key":"3738_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317\u201370.","journal-title":"Hepatol Int"},{"key":"3738_CR36","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646\u20139.","journal-title":"Br J Surg"},{"issue":"3","key":"3738_CR37","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1093\/nar\/gkn1027","volume":"37","author":"RM Cawthon","year":"2009","unstructured":"Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009;37(3):e21.","journal-title":"Nucleic Acids Res"},{"key":"3738_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol. 2018;68:268\u201379.","journal-title":"J Hepatol"},{"key":"3738_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Day CP. Genetic factors in NAFLD and NASH. Nat Rev Gastroenterol Hepatol. 2013;10:645\u201355.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3738_CR40","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1093\/hmg\/ddaa162","volume":"29","author":"M Goffredo","year":"2020","unstructured":"Goffredo M, Piombino C, Mangialavori G. Genetic determinants of metabolic traits in liver diseases: a genome-wide perspective. Hum Mol Genet. 2020;29:3451\u201362.","journal-title":"Hum Mol Genet"},{"key":"3738_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4254\/wjh.v10.i6.433","volume":"10","author":"YX Koh","year":"2018","unstructured":"Koh YX, Tan HL, Lye WK, Kam JH, Chiow AKH, Tan SS, et al. Systematic review of the outcomes of surgical resection for intermediate and advanced barcelona clinic liver cancer stage hepatocellular carcinoma: a critical appraisal of the evidence. World J Hepatol. 2018;10:433\u201347.","journal-title":"World J Hepatol"},{"issue":"3","key":"3738_CR42","doi-asserted-by":"publisher","first-page":"e0118825","DOI":"10.1371\/journal.pone.0118825","volume":"10","author":"CY Hsu","year":"2015","unstructured":"Hsu CY, Liu PH, Lee YH, Hsia CY, Huang YH, Lin HC, et al. Using serum \u03b1-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff? PLoS ONE. 2015;10(3):e0118825.","journal-title":"PLoS ONE"},{"key":"3738_CR43","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/hepr.12840","volume":"47","author":"Y Seko","year":"2017","unstructured":"Seko Y, Sumida Y, Tanaka S, Mori K, Taketani H, Ishiba H, et al. Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: association between PNPLA3 genotype and hepatocarcinogenesis\/fibrosis progression. Hepatol Res. 2017;47:1083\u201392.","journal-title":"Hepatol Res"},{"key":"3738_CR44","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00535-015-1116-6","volume":"51","author":"M Ueyama","year":"2016","unstructured":"Ueyama M, Nishida N, Korenaga M, Korenaga K, Kumagai E, Yanai H, et al. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus. J Gastroenterol. 2016;51:370\u20139.","journal-title":"J Gastroenterol"},{"key":"3738_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","volume":"61","author":"L Liu","year":"2014","unstructured":"Liu L, Patman GL, Leathart JBS, Piguet AC, Burt AD, Dufour JF, et al. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol. 2014;61:75\u201381.","journal-title":"J Hepatol"},{"key":"3738_CR46","doi-asserted-by":"publisher","first-page":"86791","DOI":"10.18632\/oncotarget.13558","volume":"7","author":"D Balasus","year":"2016","unstructured":"Balasus D, Way M, Fusilli C, Mazza T, Morgan MY, Cervello M, et al. The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population. Oncotarget. 2016;7:86791\u2013802.","journal-title":"Oncotarget"},{"key":"3738_CR47","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jcmgh.2021.11.007","volume":"13","author":"M Longo","year":"2022","unstructured":"Longo M, Meroni M, Paolini E, Erconi V, Carli F, Fortunato F, et al. TM6SF2\/PNPLA3\/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models. Cell Mol Gastroenterol Hepatol. 2022;13:759\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3738_CR48","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1038\/s41598-019-39998-2","volume":"9","author":"S Pelusi","year":"2019","unstructured":"Pelusi S, Baselli G, Pietrelli A, Dongiovanni P, Donati B, McCain MV, et al. Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease. Sci Rep. 2019;9:3682.","journal-title":"Sci Rep"},{"key":"3738_CR49","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/hep4.1618","volume":"5","author":"JV Barbosa","year":"2020","unstructured":"Barbosa JV, Lai M. Nonalcoholic fatty liver disease screening in type 2 diabetes mellitus patients in the primary care setting. Hepatol Commun. 2020;5:158\u201367.","journal-title":"Hepatol Commun"},{"key":"3738_CR50","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wai-Sun Wong V, et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology. 2021;161:1657\u201369.","journal-title":"Gastroenterology"},{"key":"3738_CR51","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","volume":"19","author":"A Torkamani","year":"2018","unstructured":"Torkamani A, Wineinger NE, Topol EJ. The personal and clinical utility of polygenic risk scores. Nat Rev Genet. 2018;19:581\u201390.","journal-title":"Nat Rev Genet"},{"key":"3738_CR52","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.1200\/JCO.2004.00.1537","volume":"23","author":"MB Thomas","year":"2005","unstructured":"Thomas MB, Abbruzzese JL. Opportunities for targeted therapies in hepatocellular carcinoma. J Clin Oncol. 2005;23:8093\u2013108.","journal-title":"J Clin Oncol"},{"key":"3738_CR53","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","volume":"10","author":"DL White","year":"2012","unstructured":"White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol. 2012;10:1342-1359.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3738_CR54","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1200\/JCO.2002.20.6.1527","volume":"20","author":"JN Vauthey","year":"2002","unstructured":"Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002;20:1527\u201336.","journal-title":"J Clin Oncol"},{"key":"3738_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF00316977","volume":"19","author":"H Bismuth","year":"1995","unstructured":"Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: Experience with 68 liver resections. World J Surg. 1995;19:35\u201341.","journal-title":"World J Surg"},{"key":"3738_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/0016-5085(93)90724-Q","volume":"105","author":"N Nagasue","year":"1993","unstructured":"Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105:488\u201394.","journal-title":"Gastroenterology"},{"key":"3738_CR57","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21037\/tgh.2019.12.19","volume":"6","author":"WC Lee","year":"2021","unstructured":"Lee WC. Value of alpha-fetoprotein in hepatocellular carcinoma. Transl Gastroenterol Hepatol. 2021;6:52.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"8","key":"3738_CR58","doi-asserted-by":"publisher","first-page":"e75982","DOI":"10.1371\/journal.pone.0075982","volume":"14","author":"L Valenti","year":"2013","unstructured":"Valenti L, Motta BM, Soardo G, Iavarone M, Donati B, Sangiovanni A, et al. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma. PLoS ONE. 2013;14(8):e75982.","journal-title":"PLoS ONE"},{"key":"3738_CR59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00535-012-0647-3","volume":"48","author":"Y Takeuchi","year":"2013","unstructured":"Takeuchi Y, Ikeda F, Moritou Y, Hagihara H, Yasunaka T, Kuwaki K, et al. The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. J Gastroenterol. 2013;48:405\u201312.","journal-title":"J Gastroenterol"},{"key":"3738_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/2193-1801-2-251","volume":"2","author":"Y Moritou","year":"2013","unstructured":"Moritou Y, Ikeda F, Iwasaki Y, Baba N, Takaguchi K, Senoh T, et al. Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C. Springerplus. 2013;2:251.","journal-title":"Springerplus"},{"issue":"1","key":"3738_CR61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12920-022-01394-7","volume":"15","author":"D Gong","year":"2022","unstructured":"Gong D, Li S, Yu Z, Wang K, Qiao X, Wu C. Contribution of PNPLA3 gene polymorphisms to hepatocellular carcinoma susceptibility in the Chinese Han population. BMC Med Genomics. 2022;15(1):248.","journal-title":"BMC Med Genomics"},{"key":"3738_CR62","doi-asserted-by":"publisher","first-page":"100647","DOI":"10.1016\/j.mgene.2020.100647","volume":"24","author":"A Delik","year":"2020","unstructured":"Delik A, Din\u00e7er S, Akk\u0131z H. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesis. Meta Gene. 2020;24:100647.","journal-title":"Meta Gene"},{"key":"3738_CR63","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13238-012-2036-3","volume":"3","author":"J Hu","year":"2012","unstructured":"Hu J, Xu Y, Hao J, Wang S, Li C, Meng S. MiR-122 in hepatic function and liver diseases. Protein Cell. 2012;3:364\u201371.","journal-title":"Protein Cell"},{"key":"3738_CR64","doi-asserted-by":"publisher","first-page":"803445","DOI":"10.3389\/fphys.2022.803445","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Peng X, Du G, Zhang Z, Zhai Y, Xiong X, et al. MicroRNA-122-5p inhibition improves inflammation and oxidative stress damage in dietary-induced non-alcoholic fatty liver disease through targeting FOXO3. Front Physiol. 2022;13:803445.","journal-title":"Front Physiol"},{"key":"3738_CR65","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jhep.2020.01.029","volume":"72","author":"RW Walker","year":"2020","unstructured":"Walker RW, Belbin GM, Sorokin EP, Van Vleck T, Wojcik GL, Moscati A, et al. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank. J Hepatol. 2020;72:1070\u201381.","journal-title":"J Hepatol"},{"issue":"Suppl1","key":"3738_CR66","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73 Suppl 1","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73 Suppl 1(Suppl1):4\u201313. https:\/\/doi.org\/10.1002\/hep.31288.","journal-title":"Hepatology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03738-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03738-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03738-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T09:03:53Z","timestamp":1741597433000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03738-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3738"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03738-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics review committee of the Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka (P\/230\/11\/2019). All methods were performed in accordance with the relevant guidelines and regulations of declaration of Helsinki. Participation of potential subjects in the research was absolutely voluntary and written informed consent was obtained from all the volunteered study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}